Invention Grant
- Patent Title: Anhydrous form of dasatinib and process for preparation thereof
- Patent Title (中): 无水形式的达沙替尼及其制备方法
-
Application No.: US12814916Application Date: 2010-06-14
-
Publication No.: US07973045B2Publication Date: 2011-07-05
- Inventor: Ondrej {hacek over (S)}imo , Ji{hacek over (r)}í Filip{hacek over (c)}ík , Alexandr Martaus , Alexandr Jegorov , Ale{hacek over (s)} Gavenda , Judith Aronhime , Pavel Vraspír , Tamás Koltai , Ji{hacek over (r)}í Faustmann , Roman Gabriel
- Applicant: Ondrej {hacek over (S)}imo , Ji{hacek over (r)}í Filip{hacek over (c)}ík , Alexandr Martaus , Alexandr Jegorov , Ale{hacek over (s)} Gavenda , Judith Aronhime , Pavel Vraspír , Tamás Koltai , Ji{hacek over (r)}í Faustmann , Roman Gabriel
- Applicant Address: IL Petah Tiqva
- Assignee: Teva Pharmaceutical Industries Ltd.
- Current Assignee: Teva Pharmaceutical Industries Ltd.
- Current Assignee Address: IL Petah Tiqva
- Agency: Kenyon & Kenyon LLP
- Main IPC: C07D239/42
- IPC: C07D239/42 ; C07D401/04
Abstract:
The invention provides anhydrous forms of dasatinib, methods for their preparation, and pharmaceutical compositions thereof.
Public/Granted literature
- US20100256158A1 POLYMORPHS OF DASATINIB AND PROCESS FOR PREPARATION THEREOF Public/Granted day:2010-10-07
Information query
